Eva Ehlich and Anja Fux of Maiwald discuss an EPO board ruling relating to the standard of disclosure concerning the novelty and sufficiency of a therapeutic effect in the context of existing case law.
All publications
Is the medical use disclosure standard different for novelty and sufficiency?, Managing IP, 2024
To the article
Authors
Dr. Anja Fux
Associate
German Patent Attorney
European Patent Attorney
UPC Representative
M.Sc. Biochemistry
